Understanding Duchenne muscular dystrophy-associated brain pathology

Understanding Duchenne muscular dystrophy-associated brain pathology

Saved in:

Bibliographic Details
Main Authors:	Minou A. T. Verhaeg, Rosanne Govaarts, Maaike van Putten
Format:	Article
Language:	English
Published:	The Company of Biologists 2025-07-01
Series:	Disease Models & Mechanisms
Subjects:	dystrophin comorbidities dmd mouse models exon skipping therapy
Online Access:	http://dmm.biologists.org/content/18/7/dmm052302
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
by: S. B. Artemyeva, et al.
Published: (2024-01-01)

Experience of observing patients with Duchenne myopathy
by: L. I. Minaycheva, et al.
Published: (2023-12-01)

Molecular Genetic Analysis of a DMD Frameshift Mutation in a Boy with Duchenne Muscular Dystrophy by MLPA and Sanger Sequencing
by: Chen Q, et al.
Published: (2025-06-01)

Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01)

Advances in Nucleic Acid Drugs and Gene Therapies based on Animal Models of Duchenne Muscular Dystrophy
by: LIU Siyu, et al.
Published: (2024-12-01)

Duchenne muscular dystrophy gene product expression is associated with survival in head and neck squamous cell carcinoma
by: Leanne Jones, et al.
Published: (2025-03-01)

Efficacy and safety of Viltepso® in Duchenne muscular dystrophy: review of clinical studies
by: V. M. Suslov, et al.
Published: (2024-11-01)

Positive experience in treating patients with Duchenne muscular dystrophy caused by a nonsense mutation: family clinical case
by: L. S. Kraeva, et al.
Published: (2024-09-01)

Multi-Modal Analysis of Satellite Cells Reveals Early Impairments at Pre-Contractile Stages of Myogenesis in Duchenne Muscular Dystrophy
by: Sophie Franzmeier, et al.
Published: (2025-06-01)

Transcriptomic profiling of skeletal muscle in the DMD mdx rat model of Duchenne muscular dystrophy
by: Abdolvahab Ebrahimpour Gorji, et al.
Published: (2025-08-01)

Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis
by: Shannon Grabich, et al.
Published: (2025-07-01)

The behavioural consequences of dystrophinopathy
by: Minou A. T. Verhaeg, et al.
Published: (2025-02-01)

Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
by: Giulio Cossu, et al.
Published: (2015-11-01)

Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part II: etiotropic approaches
by: K. S. Kochergin-Nikitskiy, et al.
Published: (2024-05-01)

Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part I: the period before etiotropic approaches introduction
by: K. S. Kochergin-Nikitskiy, et al.
Published: (2024-03-01)

Consensus concept of modern effective therapy for Duchenne muscular dystrophy
by: T. A. Gremyakova, et al.
Published: (2023-06-01)

Circulatory CCL2 distinguishes Duchenne muscular dystrophy dogs
by: Dennis O. Pérez-López, et al.
Published: (2025-03-01)

Beta-hydroxy-beta-methylbutyrate (HMB) improves daily activity and whole-body protein metabolism in Duchenne muscular dystrophy dogs: a pilot study
by: Peter P. Nghiem, et al.
Published: (2025-02-01)

The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
by: T. A. Gremyakova, et al.
Published: (2022-06-01)

DWORF expression is reduced in a large animal model of Duchenne muscular dystrophy
by: Aaron M. Gibson, et al.
Published: (2025-06-01)

Poor bone health in Duchenne muscular dystrophy: a multifactorial problem beyond corticosteroids and loss of ambulation
by: Amelia Hurley-Novatny, et al.
Published: (2024-11-01)

Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
by: Pamela Bella, et al.
Published: (2019-12-01)

Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach Distrofia muscular de Duchenne e Becker: abordagem molecular e imuno-histoquímica
by: Aline Andrade Freund, et al.
Published: (2007-03-01)

Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation
by: Kadalraja Raghavan, et al.
Published: (2025-06-01)

Brain glucose metabolism as a neuronal substrate of the abnormal behavioral response to stress in the mdx mouse, a model of Duchenne muscular dystrophy
by: Sébastien Goutal, et al.
Published: (2025-01-01)

A structural genomics approach to investigate Dystrophin mutations and their impact on the molecular pathways of Duchenne muscular dystrophy
by: Abdelbaset Mohamed Elasbali, et al.
Published: (2025-02-01)

Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO
by: Umme Sabrina Haque, et al.
Published: (2024-01-01)

Identified five variants in CFTR gene that alter RNA splicing by minigene assay
by: Bingying Zhang, et al.
Published: (2025-03-01)

Misregulation of the Ubiquitin–Proteasome System and Autophagy in Muscular Dystrophies Associated with the Dystrophin–Glycoprotein Complex
by: Manuela Bozzi, et al.
Published: (2025-05-01)

Ensartinib for advanced or metastatic non-small-cell lung cancer with MET exon 14 skipping mutations (EMBRACE): a multi-center, single-arm, phase 2 trialResearch in context
by: Yang Xia, et al.
Published: (2025-03-01)

Application of long-read sequencing in the diagnosis of Duchenne/Becker muscular dystrophy: unveiling complex structural variations and deep intronic mutations
by: Yixuan Chu, et al.
Published: (2025-07-01)

CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype
by: Antoine de Zélicourt, et al.
Published: (2022-03-01)

Genomic insights into Duchene muscular dystrophy: Analysis of 1250 patients reveals 30% novel genetic patterns and 6 novel variants
by: Khalda Amr, et al.
Published: (2024-12-01)

Duchenne muscular dystrophy: alpha-dystroglycan immunoexpression in skeletal muscle and cognitive performance Distrofia muscular de Duchenne: imunoexpressão da alfa-distroglicana em musculatura esquelética e performance cognitiva
by: Conceição Campanario da Silva Pereira, et al.
Published: (2005-12-01)

Expanding the Molecular Genetic Landscape of Dystrophinopathies and Associated Phenotypes
by: Katja Neuhoff, et al.
Published: (2024-11-01)

Complexities of care in a pediatric patient with epidermolysis bullosa acquisita and duchenne muscular dystrophy: a case report
by: Khayry Al-Shami, et al.
Published: (2025-07-01)

Intrinsic Alu affects for RNA splicing in a minigene model
by: Mina Nakama, et al.
Published: (2025-06-01)

MSI expresso: a software for determining MSI status and detecting MSI-related transcription events from RNA sequencing data
by: Emmanuel Tubacher, et al.
Published: (2025-04-01)

Importância do camundongo mdx na fisiopatologia da distrofia muscular de Duchenne The importance of mdx mouse in the pathophysiology of Duchenne's muscular distrophy
by: Sandra Lopes Seixas, et al.
Published: (1997-09-01)

Long-term, age-associated activity quantification in the DE50-MD dog model of Duchenne muscular dystrophy
by: Kamila Karimjee, et al.
Published: (2025-07-01)